Home » Topics » Regulatory » Patents

Patents
RSS

Agents for chronobiological disorders synthesized at Glaxo

Jan. 28, 1998

ACAT-inhibitory anilides from Kowa are particularly useful for atherosclerosis

Jan. 27, 1998

Takeda discloses compounds that upregulate LDL receptors

Jan. 27, 1998

Antifungal antibiotics isolated by Takara Shuzo

Jan. 27, 1998

ADIR prepares MMP inhibitors for arthritis, cancer, atherosclerosis

Jan. 27, 1998

Protein farnesyltransferase inhibitors patented by Pfizer for cancer

Jan. 27, 1998

Resistance modulators for use in cancer and malaria developed at Lilly

Jan. 27, 1998

Lilly researchers prepare novel 5-HT reuptake inhibitors

Jan. 27, 1998

Ortho reveals new fibrinogen receptor antagonists

Jan. 26, 1998

Agents for schizophrenia without EPS disclosed by Warner-Lambert

Jan. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...